Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
793.01
+2.36 (0.30%)
At close: Jul 11, 2025, 4:00 PM
792.00
-1.01 (-0.13%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Eli Lilly Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
$1,042,621
Profits / Employee
$236,306
Market Cap
711.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
Dec 31, 2021 | 35,000 | 0 | - |
Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LLY News
- 2 days ago - Eli Lilly Comes Out As ADA Winner - Seeking Alpha
- 3 days ago - Zepbound Powers Eli Lilly's Upbeat Q2 Outlook - Benzinga
- 4 days ago - US FDA approves gradual dosing for Lilly Alzheimer's drug - Reuters
- 4 days ago - FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease - PRNewsWire
- 4 days ago - Trump threatens impose up to 200% tariff on pharmaceuticals 'very soon' - CNBC
- 6 days ago - Demand for obesity drugs shoots up in India as Lilly, Novo jostle for market share - Reuters
- 6 days ago - Eli Lilly's 3-step strategy to dominate the $95 billion obesity market - Business Insider
- 9 days ago - Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns. - Barrons